Lilly Asia Ventures and Baidu Ventures helped the drug discovery software provider push its overall funding past the $310m mark.

China-headquartered molecular analytics software provider Insilico Medicine completed a $255m series C round today backed by subsidiaries of pharmaceutical firms Eli Lilly and internet group Baidu.

Lilly Asia Ventures and Baidu Ventures joined private equity firm Warburg Pincus, which led the round, and Eight Roads Ventures, a venture capital subsidiary of investment and financial services group Fidelity.

Qiming Venture Partners, Pavilion Capital, Sinovation Ventures, Bold Capital Partners, CPE, Formic Ventures, OrbiMed, Mirae Asset Capital, B Capital Group, Deerfield Management, Maison…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Robert Lavine

Robert Lavine is special features editor for Global Venturing.
Email LinkedIn